Every SEC Form 3/4/5 on record for this filer (CIK 1181174) — 7 issuers, 111 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| ILMN | ILLUMINA, INC. | Director | 2017-01-30 → 2026-05-22 | 16 | −$450,000 |
| DUK | Duke Energy CORP | Director | 2021-05-10 → 2026-05-11 | 7 | — |
| BIIB | BIOGEN INC. | Director | 2016-06-09 → 2025-06-18 | 12 | −$9M |
| NTLA | Intellia Therapeutics, Inc. | Director · lapsed | 2016-05-05 → 2022-06-16 | 11 | −$616,405 |
| GMZ | Goldman Sachs MLP Income Opportunities Fund | Director · lapsed | 2016-09-16 → 2020-09-30 | 2 | — |
| GER | GOLDMAN SACHS MLP & ENERGY RENAISSANCE FUND | Director · lapsed | 2016-09-16 → 2016-09-16 | 1 | — |
| PEG | PUBLIC SERVICE ENTERPRISE GROUP INC | Executive VP & CFO · lapsed | 2015-08-05 → 2015-08-06 | 3 | −$5M |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| BIIB | 2025-05-02 | Buy | 1,235 | $122.72 | $151,559 | 27,842 |
5 of 7 issuers are covered and open a security page; the rest are on file here only.